Dr. Zheng says the drugs have been associated with NAION, an eye condition that can cause permanent vision loss, and points to patients with risk factors.
Recap by typeshit. Video by @drlindazheng on TikTok.
The FDA had warned the Cary, North Carolina pharmacy in December 2025 about sterile production problems. Check your vial's lot number and beyond-use date.
Reuters looks at influencers pushing dietary supplements to people on weight loss drugs, turning TikTok into a sales engine for so-called GLP-1 products.
Bazaar looks at how the beauty business is reacting to GLP-1 side effects, from 'Ozempic face' to worries about collagen loss and loose skin.
Dr. Nadolsky, an obesity medicine doctor, gives his take on a recent GLP-1 warning in a short clip. Tap through to see which warning he means.
Novo Nordisk is lowering what Wegovy costs in China, a fresh move in the race for the country's obesity drug market. No figures were given.
Lilly's tirzepatide shot Zepbound now has FDA approval in a KwikPen format for weight management. Tap through for details on the new pen.
Loading…